![Custom drug screening poster](/-/media/Images/Horizon/Marketing-Images/Resources/teaser-images/poster-custom-drug-screens.png?h=392&iar=0&w=900&hash=45577B28D3DDC434D1BFA95488F39677)
Poster: Custom drug screening
See how combination drug screens helped discover agents resulting in enhanced efficacy in pre-clinical models of multiple myeloma.
'ATL313, A Potent, and Selective A2A Agonist as a Novel Drug Candidate for the Treatment of Multiple Myeloma'